Mizagliflozin
Mizagliflozin is a potent and selective SGLT1 inhibitor (Ki=27 nM for human SGLT1) with 303-fold selectivity over SGLT2. This orally active anti-diabetic agent is used in research to study postprandial glucose control and has demonstrated potential for alleviating chronic constipation in preclinical models.
Product Specifications
CAS Number
666843-10-3
Product Name Alternative
Gastrointestinal, Inhibitor, hSGLT1, hSGLT2, GSK 1614235, GSK1614235, GSK-1614235, GSK-1614235 free base, inhibit, KGA 3235, KGA3235, KGA-3235, KGA-3235 free base, Mizagliflozin, constipation, disorder, DSP3235, DSP-3235, DSP-3235 free base, DSP 3235, Chronic, antidiabetic, Sodium-dependent glucose cotransporters, SGLT, selective
Field of Research
Pharmacology & Drug Discovery
Purity
98.32% (May vary between batches)
Solubility
Methanol:250 mg/mL (442.74 mM) ; DMSO:100 mg/mL (177.09 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (7.08 mM)
Smiles
CC (C) c1[nH]nc (O[C@@H]2O[C@H] (CO) [C@@H] (O) [C@H] (O) [C@H]2O) c1Cc1ccc (OCCCNCC (C) (C) C (N) =O) cc1C
Molecular Formula
C28H44N4O8
Molecular Weight
564.67
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
495052 100 µL
UBE4B (Ubiquitin Conjugation Factor E4 B, E4, UFD2, HDNB1, UBOX3, UFD2A)
Sign In for Pricing
View Details 
MBS6429173-01 0.1 mL
NKX2-5 (CSX, CSX1, VSD3, CHNG5, HLHS2, NKX2E, NKX2.5, NKX4-1) (HRP)
Sign In for Pricing
View Details MBS6429173-02 5x 0.1 mL
NKX2-5 (CSX, CSX1, VSD3, CHNG5, HLHS2, NKX2E, NKX2.5, NKX4-1) (HRP)
Sign In for Pricing
View Details